{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-006877","form_type":"8-K","ticker":null,"cik":"0001842138","company_name":"ULIXE CORP.","filed_at":"2026-06-25T21:20:48+00:00","discovered_at":"2026-06-25T21:22:00.278993+00:00","generated_at":"2026-06-25T21:22:18.034043+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Ulixe Corp sells Ulixe Nova S.r.l. for €1.00; restructuring ahead of Nasdaq uplisting","bullets":["Sold 100% equity in Ulixe Nova to Condotti Capital S.r.l. for nominal €1.00 on June 18, 2026.","Divestiture driven by Ulixe Nova's financial constraints and capital needs; part of strategic reorganization.","Post-sale structure: Ulixe Italy owns Dale Consulting, Ulixe Pharma, MBSNet; MBSNet owns Fintexa.","Ulixe Corp previously acquired MBSNet (Nov 2025) to enhance fintech and digital payments capabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-006877","json":"https://secwatch.observer/filing/0001829126-26-006877.json","markdown":"https://secwatch.observer/filing/0001829126-26-006877.md","text":"https://secwatch.observer/filing/0001829126-26-006877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842138/000182912626006877/0001829126-26-006877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842138/000182912626006877/ulixecorp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:22:18.034043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}